1. Home
  2. UTF vs LGND Comparison

UTF vs LGND Comparison

Compare UTF & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cohen & Steers Infrastructure Fund Inc

UTF

Cohen & Steers Infrastructure Fund Inc

HOLD

Current Price

$28.00

Market Cap

3.1B

Sector

Finance

ML Signal

HOLD

Logo Ligand Pharmaceuticals Incorporated

LGND

Ligand Pharmaceuticals Incorporated

HOLD

Current Price

$299.86

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTF
LGND
Founded
N/A
1987
Country
United States
United States
Employees
N/A
68
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
2004
N/A

Fundamental Metrics

Financial Performance
Metric
UTF
LGND
Price
$28.00
$299.86
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$256.29
AVG Volume (30 Days)
241.9K
354.1K
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$1.25
Revenue Next Year
N/A
$19.41
P/E Ratio
N/A
$76.27
Revenue Growth
N/A
N/A
52 Week Low
$23.42
$131.67
52 Week High
$28.11
$326.63

Technical Indicators

Market Signals
Indicator
UTF
LGND
Relative Strength Index (RSI) 62.65 54.03
Support Level $26.54 $290.20
Resistance Level $28.11 $326.63
Average True Range (ATR) 0.29 10.96
MACD 0.00 -3.74
Stochastic Oscillator 82.89 24.94

Price Performance

Historical Comparison
UTF
LGND

About UTF Cohen & Steers Infrastructure Fund Inc

Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. Under normal market conditions, the fund invests the majority of its managed assets in securities issued by infrastructure companies, which consist of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: